 Wall Street brokerages forecast that Castle Biosciences NASDAQ:CSTL will report earnings per share of 0.42 for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Castle Biosciences earnings. The highest EPS estimate is 0.35 and the lowest is 0.48. Castle Biosciences posted earnings per share of 1.05 in the same ... 